Xenerate AB

Xeltis

Xeltis develops bioabsorbable polymer implants that regenerate into living heart valves and blood vessels for patients requiring cardiovascular replacements or hemodialysis vascular access.

Artifex

This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.

XS Innovations

This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.

Vascular Graft Solutions (VGS)

This company develops surgical devices and external supports for vein grafts for cardiac surgeons and patients undergoing bypass surgery.

VASCULAR THERAPIES

This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.

Vascular Graft Solutions

This company develops external support devices and surgical tools for vein grafts to improve outcomes in coronary and peripheral bypass surgeries for cardiac surgeons.

VenoStent

This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.

STENTiT

The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.